In particular, geographic locations, such as Southeast Asia and the Middle East, and those with higher Socio-demographic Indexes (SDI) showed a stronger correlation
[10] reported that metformin acutely and selectively increased plasma levels of GLP-1 in mice, even in the absence of concomitant oral glucose administration, while it did not increase plasma levels of the other incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), or, curiously, peptide YY, a gastrointestinal hormone co-localised with GLP-1 in L cells
Until now, users had reported various side effects of using GLP-1 drugs such as nausea, vomiting, constipation and diarrhoea, along with headaches, fatigue and changes to the skin.But now, a new potential side effect has come to light, one that could make you think you are just under the weather
Results may vary, and professional supervision is essential for safe and effective use